1. Home
  2. CLBT vs VERA Comparison

CLBT vs VERA Comparison

Compare CLBT & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

HOLD

Current Price

$12.72

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$42.26

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBT
VERA
Founded
1999
2016
Country
Israel
United States
Employees
1285
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CLBT
VERA
Price
$12.72
$42.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
$22.50
$81.30
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.45
N/A
Revenue Next Year
$17.47
$472.48
P/E Ratio
$45.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.03
$18.76
52 Week High
$20.53
$56.05

Technical Indicators

Market Signals
Indicator
CLBT
VERA
Relative Strength Index (RSI) 45.11 51.88
Support Level $11.76 $40.87
Resistance Level $15.09 $42.77
Average True Range (ATR) 0.73 2.34
MACD -0.10 0.40
Stochastic Oscillator 47.80 45.16

Price Performance

Historical Comparison
CLBT
VERA

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: